PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24814141-0	2014	Promoter variation in the catechol-O-methyltransferase gene is associated with remission of symptoms during fluvoxamine treatment for major depression.	Fluvoxamine	108-119	catechol-O-methyltransferase	Homo sapiens	26-54	
24814141-1	2014	We investigated the association between remission of depressive symptoms in fluvoxamine treatment and catechol-O-methyltransferase (COMT) gene.	Fluvoxamine	76-87	catechol-O-methyltransferase	Homo sapiens	102-130	
24814141-1	2014	We investigated the association between remission of depressive symptoms in fluvoxamine treatment and catechol-O-methyltransferase (COMT) gene.	Fluvoxamine	76-87	catechol-O-methyltransferase	Homo sapiens	132-136	
20619611-0	2010	Effect of catechol-O-methyltransferase Val(108/158)Met polymorphism on antidepressant efficacy of fluvoxamine.	Fluvoxamine	98-109	catechol-O-methyltransferase	Homo sapiens	10-38